Biomarin Pharmaceuticals
(BMRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1999 | 12-1998 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 23,410 | 9,410 |
| Marketable Securities | 39,570 | 1,970 |
| Receivables | 1,040 | 140 |
| Inventories | 670 | 70 |
| Other current assets | 1,730 | 1,220 |
| TOTAL | $66,420 | $12,810 |
| Non-Current Assets | ||
| PPE Net | 25,090 | 6,220 |
| Investments And Advances | 420 | 680 |
| Other Non-Current Assets | 11,610 | 11,770 |
| TOTAL | $37,120 | $18,670 |
| Total Assets | $103,540 | $31,500 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 3,090 | 1,340 |
| Accrued Expenses | 1,960 | 640 |
| TOTAL | $5,080 | $2,000 |
| Non-Current Liabilities | ||
| Long Term Debt | 80 | 110 |
| TOTAL | $80 | $110 |
| Total Liabilities | $5,170 | $2,110 |
| Shareholders' Equity | ||
| Common Shares | 30 | 20 |
| Retained earnings | -43,140 | -15,070 |
| Other shareholders' equity | -5,110 | -5,610 |
| TOTAL | $98,370 | $29,390 |
| Total Liabilities And Equity | $103,540 | $31,500 |